Suppr超能文献

经皮针刀松解术与局限性筋膜切除术治疗手指挛缩症的比较(Hand-2):一项随机对照试验的研究方案。

Needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (Hand-2): study protocol for a randomised controlled trial.

机构信息

Nottingham Clinical Trials Unit, University of Nottingham, Building 42 Applied Health Research, Nottingham, NG7 2, UK.

Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, BS8 2PS, UK.

出版信息

Trials. 2024 Jun 19;25(1):398. doi: 10.1186/s13063-024-08003-1.

Abstract

BACKGROUND

Dupuytren's contractures (DC) are fibrous cords under the skin of the hand that cause one or more fingers to curl gradually and irreversibly towards the palm. These contractures are usually painless but can cause a loss of hand function. Two treatments for Dupuytren's contractures are widely used within the National Health Service (NHS) in the UK: removal of the contractures via surgery (limited fasciectomy) and division of the contractures via a needle inserted through the skin (needle fasciotomy). This study aims to establish the clinical and cost-effectiveness of needle fasciotomy (NF) versus limited fasciectomy (LF) for the treatment of DC in the NHS, in terms of patient-reported hand function and resource utilisation.

METHODS/DESIGN: Hand-2 is a national multi-centre, two-arm, parallel-group randomised, non-inferiority trial. Patients will be eligible to join the trial if they are aged 18 years or older, have at least one previously untreated finger with a well-defined Dupuytren's contracture of 30° or greater that causes functional problems and is suitable for treatment with either LF or NF. Patients with a contracture of the distal interphalangeal joint only are ineligible. Eligible consenting patients will be randomised 1:1 to receive either NF or LF and will be followed up for 24 months post-treatment. A QuinteT Recruitment Intervention will be used to optimise recruitment. The primary outcome measure is the participant-reported assessment of hand function, assessed by the Hand Health Profile of the Patient Evaluation Measure (PEM) questionnaire at 12 months post-treatment. Secondary outcomes include other patient-reported measures, loss of finger movement, and cost-effectiveness, reported over the 24-month post-treatment. Embedded qualitative research will explore patient experiences and acceptability of treatment at 2 years post-surgery.

DISCUSSION

This study will determine whether treatment with needle fasciotomy is non-inferior to limited fasciectomy in terms of patient-reported hand function at 12 months post-treatment.

TRIAL REGISTRATION

International Standard Registered Clinical/soCial sTudy ISRCTN12525655. Registered on 18th September 2020.

摘要

背景

掌腱膜挛缩症(Dupuytren's contractures,DC)是手部皮下的纤维索,导致一个或多个手指逐渐不可逆地向手掌弯曲。这些挛缩通常无痛,但会导致手部功能丧失。英国国民保健制度(NHS)广泛使用两种治疗掌腱膜挛缩症的方法:通过手术切除挛缩组织(有限筋膜切开术)和通过皮肤插入的针分割挛缩组织(针刀筋膜切开术)。本研究旨在确定针刀筋膜切开术(NF)与有限筋膜切开术(LF)治疗 NHS 掌腱膜挛缩症的临床和成本效益,从患者报告的手部功能和资源利用方面进行评估。

方法/设计: HAND-2 是一项全国多中心、双臂、平行组、随机、非劣效性试验。如果患者年龄在 18 岁或以上,有至少一个未经治疗的手指,存在明确的 30°或更大的掌腱膜挛缩,导致功能问题,适合 LF 或 NF 治疗,且无远端指间关节挛缩,则有资格参加试验。不符合条件的患者包括只有远端指间关节挛缩的患者。符合条件的同意患者将按 1:1 比例随机分配接受 NF 或 LF 治疗,并在治疗后 24 个月进行随访。将使用 QuinteT 招募干预措施来优化招募。主要结局指标是治疗后 12 个月时患者报告的手部功能评估,使用患者评估测量(PEM)问卷中的手部健康状况评估(Hand Health Profile)进行评估。次要结局指标包括其他患者报告的测量指标、手指运动丧失情况以及 24 个月治疗后随访的成本效益。嵌入式定性研究将在手术后 2 年探讨患者对治疗的体验和可接受性。

讨论

本研究将确定在治疗后 12 个月时,针刀筋膜切开术在患者报告的手部功能方面是否不劣于有限筋膜切开术。

试验注册

国际标准随机对照临床试验注册(ISRCTN)ISRCTN84664342。于 2020 年 9 月 18 日注册。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验